Are specialty drug prices destroying insurers and hurting consumers?: a number of efforts are under way to reduce price pressure.

Organizations are trying to address the high cost of "specialty" medications that treat conditions such as cancer, hepatitis C, and multiple sclerosis. While comprising less than 1% of U.S. prescriptions, these drugs now account for 27% of pharmacy spending.